Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
16,681,212
-
Total 13F shares
-
1,101,849
-
Share change
-
+10,432
-
Total reported value
-
$4,368,596
-
Price per share
-
$3.97
-
Number of holders
-
7
-
Value change
-
+$41,078
-
Number of buys
-
5
Institutional Holders of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) as of Q1 2023
As of 31 Mar 2023 Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,101,849 shares of stock of the company.
Largest 7 holders included AIGH Capital Management LLC, GREENLIGHT CAPITAL INC, Worth Venture Partners, LLC, BlackRock Inc., UBS Group AG, Tradition Wealth Management, LLC, and WELLS FARGO & COMPANY/MN.
This table shows 7 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.